
dexamethasone sodium phosphate iv brand names and other generic formulations include:
Decadron Phosphate IV
lumacaftor-ivacaftor oral brand names and other generic formulations include:
Orkambi Oral
dexamethasone sodium phosphate iv and lumacaftor-ivacaftor oral
dexamethasone sodium phosphate iv will decrease the level or effect of lumacaftor-ivacaftor oral by altering drug metabolism. Blood levels of ivacaftor may be reduced by 57%, reducing the effectiveness of lumacaftor/ivacaftor. Combining these drugs is not recommended.
dexamethasone sodium phosphate iv and lumacaftor-ivacaftor oral
dexamethasone sodium phosphate iv will decrease the level or effect of lumacaftor-ivacaftor oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Strong CYP3A inducers have minimal effect on lumacaftor exposure, but decreased ivacaftor exposure (AUC) by 57%. This may reduce the effectiveness of lumacaftor/ivacaftor. Therefore, coadministration is not recommended.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant